About
Silence Therapeutics is a biotechnology company developing RNA interference (RNAi) therapeutics, advancing siRNA-based drug candidates using targeted delivery technologies to treat genetic, cardiometabolic, and other diseases. The company advances programs through preclinical and clinical development toward therapeutic applications.
Explore Silence Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.